ARCHIVES

Also NSABP’s STAR Trial Finds Raloxifene Equivalent To Tamoxifen For Breast Cancer Risk Reduction.

This article is from The Cancer Letter archive.

Vol. 32 No. 15 | April 21, 2006

Download PDF Visit The Full Archive

Related Articles

DCT Board Approves Concepts Of Eight New Biological Response Modifiers Program

July 3, 1981

NCI Supercomputer To Be Available To Extramural Scientists

June 8, 1984

NCI advisory panel recommends funding a 10-year Human Cancer Genome Project with $1.35 billion in new money.

March 18, 2005

MSKCC hopes to raise $1 billion in five-year campaign.

November 7, 2003

Correcting the Error: What U.S. News Could and Couldn’t Do to Fix the Problem

July 19, 2013

Estrogen-Only HRT Little Risk In Endometrial Cancer, GOG Study Indicates

March 26, 2004